Immediate Impact
95 standout
Citing Papers
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
Mechanical state transitions in the regulation of tissue form and function
2024 Standout
Works of L. Dixon being referenced
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| L. Dixon | 76 | 176 | 256 | 163 | 15 | 342 | |
| F Jacobsson | 106 | 84 | 166 | 112 | 14 | 347 | |
| J. E. Dalby | 263 | 188 | 235 | 157 | 18 | 405 | |
| Youwang Zhang | 189 | 96 | 132 | 152 | 14 | 315 | |
| R. Kim Davis | 189 | 122 | 159 | 148 | 19 | 360 | |
| Jean Ton Van | 249 | 128 | 202 | 218 | 14 | 408 | |
| T Yano | 45 | 171 | 243 | 152 | 21 | 344 | |
| L. Saleh-Ebrahimi | 82 | 284 | 174 | 179 | 14 | 404 | |
| Floyd Christopher Holsinger | 218 | 105 | 177 | 127 | 14 | 303 | |
| A.D. Flores | 165 | 103 | 162 | 109 | 15 | 330 | |
| Marlena McGill | 98 | 48 | 277 | 165 | 23 | 368 |
All Works
Login with ORCID to disown or claim papers
Loading papers...